Biocon’s Malaysia facility gets European regulator approval for new drug product fill finish for insulin

Supplies to Europe from this line are expected to start from the second quarter of the financial year 2027, Biocon said in its exchange filing.

Leave a Reply

Your email address will not be published. Required fields are marked *